The treatment of inflammatory-based scalp diseases is known to cause systemic as well as local adverse effects when applied topically. Therefore, the project aimed at developing a drug that accumulates selectively in the hair follicle and that releases only limited quantities of the drug to the skin.
> more: Nanocapsules can make drugs more skin-tolerable.
